| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/27/2008 | CN100413885C Modified proteins, designer toxins and methosd of making thereof |
| 08/27/2008 | CN100413884C Process for extracting protein/polypeptide-K from i(momordica charantia), products and use thereof |
| 08/27/2008 | CN100413883C Peptidic compounds selectively binding to p-selectin |
| 08/26/2008 | US7417180 Genes for increasing grain yield and uses thereof |
| 08/26/2008 | US7417178 Expression of human milk proteins in transgenic plants |
| 08/26/2008 | US7417136 Containing transcriptional units which encode a signal sequence of one flavivirus and an immunogenic flavivirus antigen of a second flavivirus; Japanese encephalitis virus (JEV), West Nile virus (WNV) or related flaviviruses |
| 08/26/2008 | US7417134 IL-1 receptor based cytokine traps and method of using |
| 08/26/2008 | US7417133 Methods for obtaining thermostable enzymes, DNA polymerase I variants from Thermus aquaticus having new catalytic activities, methods for obtaining the same, and applications of the same |
| 08/26/2008 | US7417130 DNA library comprising nucleotide sequences coding polypeptide containing leucine repeats for monitoring binding and regulation of ligand and cofactor interactions |
| 08/26/2008 | US7417128 7C10 and 16C10 CD80-specific antibodies |
| 08/26/2008 | US7417125 Chimeric humanized monoclonal antibody for treating tumors and inflammation |
| 08/26/2008 | US7417123 PRO4399 Antibodies |
| 08/26/2008 | US7417122 Mammalian galanin receptors |
| 08/26/2008 | US7417121 vectors, host cells, and recombinant and synthetic methods for producing said polypeptides; polypeptide has N-formyl peptide receptor activity |
| 08/26/2008 | US7417120 Protein for use in the treatment of inflammation, allergies, asthma and leukemias |
| 08/26/2008 | US7417117 higher sensitivity to cAMP and/or higher selectivity for cAMP compared to cGMP in comparison with the wild type; comprises a bovine alpha 3 subunit which has been modified at a binding site for cyclic nucleotides in the position corresponding to threonine T537 |
| 08/26/2008 | US7417116 isolated PRO polypeptide which is either transmembrane domain-deleted or transmembrane domain-inactivated |
| 08/26/2008 | US7417115 For stimulating release of tumor necrosis factor and/or cellular differentiation of chondrocytes, endothelial cells or adipocytes by contacting blood with pro-polypeptide; cancer diagnosis and treatment |
| 08/26/2008 | US7417113 Antitumor agents; anticancer agents; antibody binding |
| 08/26/2008 | US7417112 Multiblock copolymers having improved mechanical properties |
| 08/26/2008 | US7417027 For decreasing food intake; eating disorders; sexual disorders |
| 08/26/2008 | US7417026 Mobilization of hematopoietic cells |
| 08/26/2008 | US7417025 Use of poly-α2,8-sialic acid mimetic peptides to modulate NCAM functions |
| 08/26/2008 | US7416887 Preparing viable stem cells in culture; prepare nutrient broth containing ligand and preferential receptor, inoculate with cells, monitor propagation and viability of cells |
| 08/26/2008 | US7416885 Proliferation factor is obtained from the UCHT1 rat thyroid cell line, or a fragment, analogue or derivateve |
| 08/26/2008 | US7416881 Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor |
| 08/26/2008 | US7416878 Immunogenic compositions including rough phenotype Brucella host strains and complementation DNA fragments |
| 08/26/2008 | US7416877 Type I transmembrane; cytokine receptor proteins having immunoregulatory activity; isolated DNA, recombinant expression vectors, transformed or transfected cells, monoclonal antibodies |
| 08/26/2008 | US7416875 modified to be cytotoxic by altering its amino acid sequence so that it is not bound easily by the ribonuclease inhibitor while still retaining catalytic properties |
| 08/26/2008 | US7416874 For use in food and feeds |
| 08/26/2008 | US7416873 Such as the Abl tyrosine kinase domain; leukemia |
| 08/26/2008 | US7416863 use of the polynucleotide sequences as hybridization probes; comprising a polynucleotide sequence which codes for the lysR2 gene |
| 08/26/2008 | US7416859 Bacterial shuttle vectro for transfer of heterologous nucleotide sequences into cells; improving exogenous gene expression |
| 08/26/2008 | US7416858 Forming a convalent conjugate of a peptide, removing X2 or a saccharyl subunit thereof from peptide forming a truncated glycan; contacting truncated glycan with glycosyltransferase and modified sugar donor under conditions suitable for glycosyltransferase to transfer a modified sugar moiety |
| 08/26/2008 | US7416853 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| 08/26/2008 | US7416852 detection of the immunocomplexes between the antibodies and the polypeptides indicates the presence of antibodies specific for Porphyromonas gingivalis in the test sample |
| 08/26/2008 | US7416849 HBM variants that modulate bone mass and lipid levels |
| 08/26/2008 | US7416848 DNA encoding SNORF25 receptor |
| 08/26/2008 | US7416847 Constructing an expression library by the use of proteins which covalently bind DNA which is expressed in such a way that the protein so expressed binds to its own encoding DNA, therefore allowing the DNA to be associated only with its encoding protein; cloning; genetic engineering |
| 08/26/2008 | US7416846 A vaccine composition comprising virus-like particles (VLPs) containing L1 proteins or functional L1 protein derivatives from human papillomavirus (HPV) 16, HPV 18, HPV 31 and HPV 45 genotypes and an adjuvant;anticarcinogenic agents; antumor agents; viricides |
| 08/26/2008 | US7416839 Immunoassay; for therapeutic treatment of Bovine spongiform encephalopathy (BSE) in cows, Scrapie disease in sheep and Creutzfeldt-Jacob syndrome in humans |
| 08/26/2008 | US7416733 inhibiting Flavivirus infection by inhibiting the fusion between the virion envelope and a cell membrane; E1 envelope glycoprotein of hepaciviruses and E2 envelope glycoprotein of pestivirus have previously undescribed structures, truncated class II fusion proteins |
| 08/26/2008 | US7416732 truncated papillomavirus L1 protein consisting of an amino acid sequence having one or more carboxy terminal amino acid residues deleted from a full length L1 amino acid sequence, and amino acid residues from a second protein replacing deleted amino acid residues in the truncated L1 protein. |
| 08/26/2008 | US7416731 diagnosis and treatment of hair loss; producing the antibody by immunizing an animal with a Hairless antigen; conjugating the Hairless protein to a carrier |
| 08/26/2008 | US7416730 Derivatives of the IL-2 receptor gamma chain, their production and use |
| 08/26/2008 | US7416729 Immunotherapy; combination with codeine phosphate, naproxen, diclofenac, indomethacin, or ibuprofen |
| 08/26/2008 | US7416725 Compositions and methods of using galectin-8 as an inhibitor of tumor cell growth |
| 08/26/2008 | CA2400007C Immunization of an individual against carcinoma and the preliminary stages thereof |
| 08/26/2008 | CA2374667C Synthetic ligation reassembly in directed evolution |
| 08/26/2008 | CA2295190C Improved protein expression strains |
| 08/26/2008 | CA2277112C Use of exendins and agonists thereof for the reduction of food intake |
| 08/21/2008 | WO2008101160A2 Htra1-pdz and htra3-pdz modulators |
| 08/21/2008 | WO2008101017A2 Glucagon/glp-1 receptor co-agonists |
| 08/21/2008 | WO2008100966A1 Gdnf-derived peptides |
| 08/21/2008 | WO2008100609A1 A novel antitoxin and vaccine platform based on nodavirus vlps |
| 08/21/2008 | WO2008100578A2 Method of isolating antibodies by precipitation |
| 08/21/2008 | WO2008100384A2 Activin-actriia antagonists and uses for promoting bone growth in cancer patients |
| 08/21/2008 | WO2008100376A2 Truncation variants of sirt1 and methods of use thereof |
| 08/21/2008 | WO2008100122A1 Oligomerizaed protein transduction domains, a method for preparing the same and an intracellular transduction method using the same |
| 08/21/2008 | WO2008099451A1 Method of designing high-functional protein by comprehensive amino acid substitution |
| 08/21/2008 | WO2008099405A2 Secreted pate-like proteins |
| 08/21/2008 | WO2008099189A2 Herpes simplex viruses and methods of viral replication |
| 08/21/2008 | WO2008098995A2 Genes involved in mitochondrial biogenesis |
| 08/21/2008 | WO2008098958A1 C-terminal attachment of two chemical groups to peptides |
| 08/21/2008 | WO2008098909A1 Prevention and treatment of sub-clinical pcvd |
| 08/21/2008 | WO2008098796A1 Polypeptide comprising a knottin protein moiety |
| 08/21/2008 | WO2008098749A2 Peptides derived from the major allergen of ragweed (ambrosia artemisiifolia) and uses thereof |
| 08/21/2008 | WO2008098720A1 Therapeutic application of kazal-type serine protease inhibitors |
| 08/21/2008 | WO2008098484A1 Recombinant l1 proteins of human papilloma virus and uses thereof |
| 08/21/2008 | WO2008098377A1 Serpine1 polymorphisms are predictive of response to activated protein c administration and risk of death |
| 08/21/2008 | WO2008098368A1 Inhibitors of hepatitis c ns3 protease |
| 08/21/2008 | WO2008098280A1 Methods for the synthesis of dicarba bridges in growth hormone peptides |
| 08/21/2008 | WO2008078167A3 Consensus peptide |
| 08/21/2008 | WO2008077413B1 Dna vaccines for fish |
| 08/21/2008 | WO2008075349B1 Therapeutic methods using a thymus peptide |
| 08/21/2008 | WO2008066749A3 Multi-epitope peptide-loaded dendritic cell immunotherapy for cancer |
| 08/21/2008 | WO2008054464A3 Broad spectrum immune and antiviral gene modulation by oral interferon |
| 08/21/2008 | WO2008039173A3 Methods and compositions for inhibiting cell death or enhancing cell proliferation |
| 08/21/2008 | WO2008022774A3 Biosilica-adhesive protein nanocomposite materials: synthesis and application in dentistry |
| 08/21/2008 | WO2008015239A3 Muteins of tear lipocalin and methods for obtaining the same |
| 08/21/2008 | WO2008010902A3 Regulation of tlr signaling by complement |
| 08/21/2008 | WO2007120614A3 Homogeneous erythropoietin and other peptides and proteins, methods and intermediates for their preparation |
| 08/21/2008 | WO2007084158A3 Novel use |
| 08/21/2008 | WO2007077398A9 Gene promoters that can be used in plants |
| 08/21/2008 | WO2007010459B1 Protein extracted from plants of the genus lupinus or produced in recombinant form, nucleotide sequence encoding it and its use in animal nutrition, as a plant growth promoter and in the fight against pathogenic fungi |
| 08/21/2008 | US20080201800 Antifungal Plant Proteins and Methods of Their Use |
| 08/21/2008 | US20080201799 Protein kinase stress-related proteins and methods of use in plants |
| 08/21/2008 | US20080201789 Variants and exons of the glyt1 transporter |
| 08/21/2008 | US20080201123 Increased activity and efficiency of expansin-like proteins |
| 08/21/2008 | US20080200665 Nucleotide sequences coding gramnegative bacterial lipoprotein for use in prevention and treatment of microorganismal infection; genetic vaccine |
| 08/21/2008 | US20080200664 Nucleotide sequences coding transcription factor (p63) for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 08/21/2008 | US20080200657 Mutant of Granulocyte-Colony Stimulating Factor (G-Csf) and Chemically Conjugated Polypeptide Thereof |
| 08/21/2008 | US20080200650 Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use |
| 08/21/2008 | US20080200649 Method |
| 08/21/2008 | US20080200646 and cerebral ischemia and or the onset of systemic inflammatory response particularly when associated with a surgical procedure(especially cardiothoracic surgery; kit comprising a dry lyophilized kallikrein inhibitor DX88 in a hermetically sealed container (rather than aprotinin) |
| 08/21/2008 | US20080200641 Protein engineering; catalyzed coupling introduction of nonnatural amino acids into polypeptides in presence of micelles and/or DTT; retaining native function |
| 08/21/2008 | US20080200415 Plant Activation of Insect Toxin |
| 08/21/2008 | US20080200414 HCaRG, A Novel Calcium-Regulated Gene |
| 08/21/2008 | US20080200411 Modulating ATP gated ion channel P2X7R protein; administering agonistic agent; depression, anxiety, bipolar disorder |
| 08/21/2008 | US20080200396 Peptides or Peptidic Conjugate Derivatives of Msh and the Use Thereof for Cosmetically Fighting Against Canities |